<DOC>
	<DOCNO>NCT00391521</DOCNO>
	<brief_summary>This Phase I trial . Some specific protocol information proprietary publicly available time . Full information provide trial participant .</brief_summary>
	<brief_title>AS703569 Phase I Patients With Solid Tumours</brief_title>
	<detailed_description />
	<criteria>1 . Histopathologically confirm locally advanced metastatic solid tumour either refractory standard care therapy disease standard care therapy reliably effective cancer standard therapy exist 2 . Age great equal 18 year 3 . Has read understands informed consent form willing able give inform consent , subject authorization Health Insurance Portability Accountability Act ( HIPAA ) . Fully understand requirement study willing comply study visit assessment 4 . Subjects partner must willing avoid pregnancy study 1 month last study drug administration . Males female partner childbearing potential female subject childbearing potential must therefore willing use adequate contraception , intra uterine device , diaphragm , condom , duration study . For purpose study , childbearing potential define : `` All female subject unless post menopausal least two year , surgically sterile sexually inactive '' 5 . Negative serum pregnancy test screen visit woman childbearing potential 1 . Bone marrow impairment evidence Hb &lt; 9.0 g/dl , ANC &lt; 1.5x 109/L , platelet &lt; 75 x 109/L . Subjects may transfuse . 2 . Renal impairment evidence serum creatinine &gt; 1.5 x ULN ( upper limit normal ) , and/or calculate creatinine clearance &lt; 60 ml/min 3 . Liver function abnormality define total bilirubin &gt; 1.5 ULN , AST ALT &gt; 2.5x ULN screening ; subject liver involvement AST ALT &gt; 5x ULN screen 4 . INR ( blood coagulation ) &gt; 1.5 x ULN subject therapeutic dos coumadin 5 . History CNS metastases , unless subject previously treat CNS metastasis , stable CT scan without evidence cerebral edema , requirement corticosteroids anticonvulsant 6 . History difficulty swallowing , malabsorption chronic gastro intestinal disease condition may hamper compliance and/or absorption test product 7 . Eastern Cooperative Oncology Group Performance Status ( ECOG PS ) &gt; 2 8 . Known HIV , hepatitis C , hepatitis B positivity 9 . Has receive chemotherapy , immunotherapy , hormonal therapy , biologic therapy , anticancer therapy surgical intervention within 28 Days Day 1 study drug treatment ( 6 week nitrosureas mitomycin C ) , must fully recover 10 . Has receive extensive prior radiotherapy 30 % bone marrow reserve , prior bone marrow/stem cell transplantation 11 . Has receive investigational agent within 28 day Day 1 12 . Has history significant medical disease intervention include major gastric small bowel surgery psychiatric condition might impair subject wellbeing preclude full participation study 13 . Is pregnant nursing female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Oncology . All solid Tumour disease .</keyword>
</DOC>